Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07053254

The Characteristics and Treatment Mechanism of Vascular Grafts in Elderly Patients With CAOD Through Single-cell Transcriptome Analysis

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study aims to establish a cardiovascular biobank using vascular grafts obtained from participants with coronary artery occlusive disease (CAOD). Through genomic and transcriptomic analyses, the study seeks to characterize the biological features of the vascular grafts and identify potential therapeutic targets and mechanisms related to vascular remodeling and stiffness.

Detailed description

This observational study will utilize discarded vascular graft tissues obtained during coronary artery bypass grafting (CABG) procedures in participants with coronary artery occlusive disease (CAOD). Our surgical team performs over 200 CABG operations annually, allowing for the consistent and ethical acquisition of excess graft tissue without requiring any additional procedures or interventions for participants. Collected tissues will be processed as follows: A portion of each graft will be preserved in RNAlater solution for molecular analyses, including total RNA sequencing, quantitative PCR, and western blotting. Another portion will be fixed in formalin and embedded for histological examination, including immunohistochemistry (IHC), to validate mechanisms of vascular remodeling and stiffness at the protein level. This approach ensures that all biological samples are collected with minimal risk and no additional burden to participants, while enabling comprehensive multi-omic analysis to investigate the pathophysiological characteristics of vascular grafts in elderly CAOD patients.

Conditions

Timeline

Start date
2022-04-12
Primary completion
2027-04-11
Completion
2027-04-11
First posted
2025-07-08
Last updated
2025-07-08

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07053254. Inclusion in this directory is not an endorsement.